期刊文献+

STZ诱导C57BL小鼠T1DM模型优化的研究 被引量:7

Improved investigation of C57BL mices T1DM modol induced by STZ
下载PDF
导出
摘要 目的探索制备T1DM小鼠模型优化条件,为研究T1DM病因及发病机理提供理想的动物模型。方法分别应用不同剂量、不同性别小鼠以小剂量、多次注射链脲佐菌素方法(multiple low dose of streptozotocin,MLDS)制备T1DM小鼠糖尿病模型,动态监测小鼠血糖水平、体重的变化,比较不同方法糖尿病模型成功率与糖尿病小鼠死亡率。结果MLDS诱导雌性C57BL小鼠T1DM模型STZ小剂量组模型成功率为0,死亡率为22.06%。STZ大剂量组模型成功率为57.14%,死亡率为28.56%;MLDS诱导C57BL雄性小鼠T1DM模型的结果,T1DM组小鼠模型成功率为75%,死亡率为20%;MLDS诱导雄性C57BL小鼠T1DM模型再研究结果,T1DM组小鼠模型成功率为84.6%,死亡率为0。结论C57BL雄性小鼠更适合用于制备MLDS诱导T1DM模型,65 mg/kg.BW STZ造模剂量优于其它三种剂量。 Objective To investigate the methods of TIDM mites model induced by SIZ for preparing a better mites TIDM model.Methods To induce TIDM mices model with the injection of MLDS of different dosages of streptozotocin, female and male mices respectivdy.The blood glucose, body weight,DM incidence,and DM mortality of mices model were inspected.Results DM incidence and mortality was 0% and 22.06% in C57BL female T1DM model mices; the incidence and mortality was 75% and20% respectively in C57BL male TIDM model mices; the DM incidence was 为 84.6% but its mortality was 0% in C57BL male TIDM model mlces induced by STZ65mg. BW. Couclusion The better TIDM mice model was made in C57BL male mices and injection of STZ65 mg.BW.with MLDS.
出处 《中国实验诊断学》 2007年第1期36-39,共4页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技厅国际合作项目资助(20020704) 吉林大学本科生研究计划资助
关键词 T1DM 糖尿病小鼠模型 链脲佐菌素 MLDS方法 type 1 diabetes mice model muifilde low dose of streptozotocin
  • 相关文献

参考文献14

  • 1王姮.预防1型糖尿病的可能性[J].中华内分泌代谢杂志,2001,17(1):5-6. 被引量:10
  • 2Mathews CF, Graser RT, Baglay RJ,et al. Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice,a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress [J]. Immunogenetecs,2003,55(7):491.
  • 3Brodnicki TC, Quirk F, Iorahan G. A susceptibility allele from a nondiabetes-prone mouse strain accelerates diabetes in NOD congcnie mice[J].Diabetes, 2003,52(1): 218.
  • 4Kagi D, Ho A, Odermatt B, et al. TNF receptor 1 -dependent beta cell toxicity as an effector pathway in autoimmune diabetes[J].J Immunal, 1999,162(8):4598.
  • 5Lamagawa O,Shimizu J,Vaupel BA.Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD)mice[J].J Immunol,2000,164(10):5466.
  • 6余奇文,李宁丽,张冬青,聂红,周光炎.可溶性Fas,可溶性Fas配体与细胞因子在1型糖尿病发病中的意义[J].中华内分泌代谢杂志,2001,17(1):31-33. 被引量:5
  • 7Chervonsky AV, Wang Y, Wong FS, et al. The role of Fas in autoimmunine diabetes[J]. Cell, 1997,89:17.
  • 8Tabatabaie T, Grahem KL, Vasquez AM, et al. Inhibition of the cytokinemediated inducible nitric oxide synthase expression in rat insulinana cells by phenylN-tert-butyInitrone[J]. Nitric Oxide,2000,4(2): 157.
  • 9Benov L, Batinic-Haberle I. A manganese porphyrin suppresses oxidative stress and extends the life span of streptozotocin-diabetic rats [J]. Free Radic Res,2005 ,39(1):81.
  • 10Dursun E,Timur M, Dursun B, Suleymanlar G, Ozben T. Protein oxidation in Type 2 diabetic petients on hemodialysis[J].J Diabetes Complications,2005, 19(3): 142.

二级参考文献1

共引文献13

同被引文献101

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部